Minimal Hepatic Encephalopathy Clinical Trial
Official title:
Acetyl-L-Carnitine Reduces Depression and Improves Quality of Life in Patients With Minimal Hepatic Encephalopathy
Minimal hepatic encephalopathy represents a common complication present in well-compensated cirrhotic patients that impairs patients daily functioning and health-related quality of life. Acetyl-L-carnitine has been shown to be useful in improving blood ammonia and cognitive functions in cirrhotic patients with minimal hepatic encephalopathy. This study evaluated the effects of acetyl-L-carnitine treatment on health related quality of life and on depression in patients with minimal hepatic encephalopathy.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04244877 -
Rifaximin's Effect on Covert Hepatic Encephalopathy With SIBO and Gastrointestinal Dysmotility
|
Phase 3 | |
Completed |
NCT00992290 -
Probiotic Lactobacillus GG (LGG) in Patients With Minimal Hepatic Encephalopathy
|
Phase 1 | |
Completed |
NCT00312078 -
Effect of Yogurt on Minimal Hepatic Encephalopathy
|
N/A | |
Completed |
NCT04058327 -
A Study of MHE in Patients With Liver Diseases
|
||
Completed |
NCT02767622 -
Reversibility of Minimal Hepatic Encephalopathy Following Liver Transplantation
|
N/A | |
Completed |
NCT03585257 -
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
|
Phase 2 | |
Recruiting |
NCT01083446 -
A Nutritional Approach to Minimal Hepatic Encephalopathy
|
N/A | |
Completed |
NCT02520817 -
Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study
|
N/A | |
Terminated |
NCT00811434 -
Study of Lactulose in Children With Chronic Liver Disease
|
Phase 2 | |
Completed |
NCT00375375 -
Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
|
Phase 4 | |
Completed |
NCT04077125 -
Transcranial Doppler Ultrasound and Minimal Hepatic Encephalopathy
|
||
Completed |
NCT01069133 -
Study of Rifaximin in Minimal Hepatic Encephalopathy
|
Phase 1/Phase 2 | |
Completed |
NCT01847651 -
Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
|
Phase 4 | |
Completed |
NCT01135628 -
Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
|
N/A |